Ruby Prosser Scully's profile photo

Ruby Prosser Scully

Australia

Managing Editor at The Medical Republic

Managing editor @medicalrepublic. Bylines in @newscientist, @guardian, @Nature, @cosmosmagazine and others. @[email protected]

Articles

  • 4 days ago | medicalrepublic.com.au | Ruby Prosser Scully

    Testing blood eosinophils at admission could have ‘significant prognostic implications’, say researchers. Elderly COPD patients with a blood eosinophil count of 150 cells/μL or more on admission to hospital for covid are significantly more likely to develop respiratory and systemic complications than those without COPD.

  • 4 days ago | medicalrepublic.com.au | Ruby Prosser Scully

    Tirzepatide shows substantial reductions in weight and waist circumference reductions in a comparison trial with semaglutide. Tirzepatide (Mounjaro, Eli Lilly) may surpass semaglutide (Wegovy, Novo Nordisk) for weight loss in patients with obesity and no diabetes, according to new research in the NEJM.

  • 1 week ago | medicalrepublic.com.au | Ruby Prosser Scully

    New guidance for GPs highlights the best tools and interventions to help women. Prevention strategies such as assessing risk factors, chemoprevention and surgery are vital in the fight to reduce the rising incidence of breast cancer, says an Australian expert. GPs are on the frontline when it comes to initiating these strategies, outlined in new guidance in the AJGP.

  • 1 week ago | medicalrepublic.com.au | Ruby Prosser Scully

    These low-risk options are ‘highly effective’ at reducing the risks of high-grade taxane-induced neuropathy. Cancer patients who were treated with hand cooling or compression were significantly less likely to develop grade 2 or higher chemotherapy-induced peripheral neuropathy, according to new research. The researchers randomly assigned 122 women with primary breast cancer to receive either compression or cooling of their dominant hand, with their non-dominant hand used as a control.

  • 1 week ago | puffnstuff.com.au | Ruby Prosser Scully

    These low-risk options are ‘highly effective’ at reducing the risks of high-grade taxane-induced neuropathy. Cancer patients who were treated with hand cooling or compression were significantly less likely to develop grade 2 or higher chemotherapy-induced peripheral neuropathy, according to new research. The researchers randomly assigned 122 women with primary breast cancer to receive either compression or cooling of their dominant hand, with their non-dominant hand used as a control.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
552
Tweets
2K
DMs Open
Yes
Ruby PS
Ruby PS @rubyprosser
16 May 23

RT @Medicalrepublic: We're hiring! Editor – national health daily (fulltime, hybrid). Are you a creative, energetic & experienced news jour…

Ruby PS
Ruby PS @rubyprosser
15 May 23

RT @johnbuckley_: Vice, Decayed Digital Colossus, Files for Bankruptcy https://t.co/Op1sSVkQAl

Ruby PS
Ruby PS @rubyprosser
14 May 23

The TGA, FDA and EMA have all slapped a warning on JAK inhibitors. Only suitable if no alternatives are available https://t.co/Z8fwHHkPII @medicalrepublic